Stay updated on Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a newer revision of the page metadata associated with an updated release of the document.
    Difference
    0.0%
    Check dated 2026-05-18T04:15:40.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    In the Taiwan locations list, the Taoyuan District entry was removed and replaced with Taoyuan, Taiwan, 333, preserving the same site code. This reflects a standardization of the city name in the study's locations.
    Difference
    0.0%
    Check dated 2026-05-03T19:36:49.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor technical update with no change to the displayed study record content.
    Difference
    0.0%
    Check dated 2026-04-26T15:21:57.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:35:58.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The study location entry was updated from Padua, Veneto, Italy, 35128 to Padova, Veneto, Italy, 35128.
    Difference
    0.0%
    Check dated 2026-04-05T06:19:24.000Z thumbnail image
  9. Check
    79 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as the condition, included the Genetic and Rare Diseases Information Center as a resource, and updated the location entry from Napoli to Naples, Campania, Italy (80131) with revision to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T16:51:58.000Z thumbnail image

Stay in the know with updates to Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.